Roy Proujansky
Direktor/Vorstandsmitglied bei Rheonix, Inc.
Profil
Roy Proujansky is currently the CEO-Delaware Valley Operations & Executive VP at Dupont Hospital for Children and also serves as the Director at Rheonix, Inc. He previously worked as the Chairman-Pediatrics Department & Associate Dean at Sidney Kimmel Medical College from 2000 to 2006, as the Chief Operating Officer & EVP-Patient Operations at The Nemours Foundation from 2006 to 2013, and as an Independent Director at 9 Meters Biopharma, Inc. from 2018 to 2020.
He also worked as an Assistant Professor at the University of Pittsburgh School of Medicine.
Dr. Proujansky received his undergraduate degree from Northwestern University in 1978, his doctorate from Northwestern University in 1980, and his MBA from the University of Massachusetts.
Aktive Positionen von Roy Proujansky
| Unternehmen | Position | Beginn |
|---|---|---|
| Dupont Hospital for Children | Corporate Officer/Principal | 01.07.2013 |
Rheonix, Inc.
 Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Direktor/Vorstandsmitglied | 29.01.2021 |
Ehemalige bekannte Positionen von Roy Proujansky
| Unternehmen | Position | Ende |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 30.06.2020 |
The Nemours Foundation
 The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Geschäftsführer | 01.07.2013 |
| Sidney Kimmel Medical College | Corporate Officer/Principal | 01.01.2006 |
| University of Pittsburgh School of Medicine | Corporate Officer/Principal | - |
Ausbildung von Roy Proujansky
| Northwestern University | Doctorate Degree |
| University of Massachusetts | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Rheonix, Inc.
Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Health Technology |
The Nemours Foundation
The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Miscellaneous |
| Dupont Hospital for Children |
